Related Experiment Video
Updated: Oct 2, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Benzamide-based thiolcarbamates: a new class of HIV-1 NCp7 inhibitors
Atul Goel1, Sharlyn J Mazur, Rasem J Fattah
1Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Abstract:
The HIV-1 nucleocapsid protein NCp7, which contains two highly conserved zinc fingers, is being used as a novel target for AIDS therapy due to its pivotal role in viral replication and its mutationally intolerant nature. Herein we report a new class of NCp7 inhibitors that possess good antiviral activity with low cellular toxicity.
Related Concept Videos
Antiviral Nucleoside Inhibitors
Subviral Agents
Inhibitors of Virion Maturation and Assembly
Anthelminthic Agents
Antihypertensive Drugs: Thiazide-Class Diuretics
Therapeutic Drug Monitoring: Overview and Classification

